Does the Recall by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?

Not Applicable

• Conditions: Colorectal Cancer
• Interventions: Other: Control; Other: Co-signed Letter

• Registration Number: NCT01279330
• Lead Sponsor: University of Paris 5 - Rene Descartes

Brief Summary

The propose of this study is to assess the effect of general practitioner's involvement in the stimulus invitation letter in colorectal cancer screening compared to sending the patient home test (stimulus 2 of reference as contained in the specifications).

Detailed Description

Not available

Study Timeline

• Status Verified: 2010-09
• Study Start: 2010-09
• Study First Submitted: 2011-01-18
• Study First Submitted QC: 2011-01-18
• Last Update Submitted: 2011-01-18
• Study First Posted: 2011-01-19
• Last Update Posted: 2011-01-19
• Primary Completion: 2011-04
• Study Completion: 2011-04

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1569

Inclusion Criteria

• Age : 50 to 74 years.
• Not having answered the first two solicitations of ADECA75 to participate in screening for colorectal cancer

Exclusion Criteria

• Patients who have a Fecal Occult Blood Test for less than 2 years or a colonoscopy within the past 5 years or excluded for medical reasons (according to information known from ADECA).

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Control	Control	Patients receive by mail the materials needed for stool samples.
Co-signed Letter	Co-signed Letter	-

Primary Outcome Measures

Name	Time	Method
Completion of Fecal Occult Blod Test	7 months	Increased number of patients who completed the test for faecal occult blood following the first solicitation with the letter co-signed by general practitioner, compared with the conventional solicition(including replies exclusions).

Secondary Outcome Measures

Name	Time	Method
Delays from receipt of the letter and the completion of the test.	7 months
Proportion of uninterpretable test.	7 months

Trial Locations

Locations (1)

Université Paris Descartes; 🇫🇷 Paris, Ile de France, France